Home > Portfolio

Current investments

		Skyline Diagnostics B.V. Development of biochips for acute myeloid leukemia, brain tumors and myeloma (Kahler’s disease).



		Cavadis B.V. Development of diagnostic and therapeutic tools for the treatment of vulnerable plaques



		River Diagnostics B.V. Development of medical diagnostic instruments in the field of micro-organism identification and skin composition analysis.



		Arcarios B.V. Development of novel disease-modifying therapeutics in the field of bone and joint diseases.



		arGen-X B.V. Development of novel, antibody-based medicines with the potential to make a meaningful impact on patients' lives.

Development of biochips for acute myeloid leukemia, brain tumors and myeloma (Kahler’s disease).